Biocon Biologics gains market access coverage for Yesintek in the US
Yesintek is a biosimilar to Stelara (ustekinumab) and is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.